This page is only intended for UK healthcare professionals. Adverse event reporting can be found near the bottom of the page.
Tillotts Products may be discussed in the content of these modules where prescribing information will be available.

Modules

Modules include

Introduction to CDI and treatment guidelines

This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.

Approx Length

30 minutes

Antimicrobial Stewardship

This module aims to provide you with an introduction to Antimicrobial Stewardship (AMS) with a focus on AMS principles. This module was co-developed with a practicing pharmacist, Dr Stephen Hughes, bringing together clinical insights and current evidence and guidelines and the realities of day-to-day decision making.

Approx Length

60 minutes

Managing CDI in Vulnerable Patients

This module consists of two recorded Tillotts symposia, offering practical, clinician-led insights into the management of CDI in high-risk patients. Through recorded sessions, expert healthcare professionals share real-world strategies for recognising, treating, and supporting patients with conditions such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).

Approx Length

60 minutes

Introduction to CDI and treatment guidelines

This module covers the symptoms and complications of C. difficile infection, how the infection is transmitted, the risk factors associated with getting the infection and its treatment and prevention.

Approx Length

30 minutes

CDI testing and diagnosis

This module covers the signs and symptoms of CDI, differential diagnosis, the two step diagnostic algorithm as well as an overview of the laboratory tests for CDI diagnosis.

Approx Length

30 Minutes

Assessment of acute diarrhoea: NICE guidelines

The management of acute diarrhoea in adults including its assessment, how it should be investigated in primary care and finally information on sending a stool sample.

Approx Length

20 minutes

Patient and carer stories of C.diff

This module highlights the human burden of CDI and the psychological impact it has on patients diagnosed with the infection.

Approx Length

18 minutes

C.diff Decoded: Insights from experts

This module provides a brief summary of four clinical papers presented by one of their authors, Dr Simon Goldenberg, Dr Kerrie Davies and Dr Tim Planche.

Approx Length

30 minutes

Antibiotics for CDI

This module gives a brief overview of antimicrobials for the treatment of CDI.

Approx Length

30 minutes

Human burden of CDI

The impact of CDI on health-related quality of life, the impact on patients work-life, the impact of recurrent CDI, and long-lasting impact on QoL that CDI can cause.

Approx Length

14 minutes

CDI epidemiology

A brief overview of C.difficile infection epidemiology, the incidence of CDI, the epidemiology of community-acquired CDI, CDI risk factors, antibiotic-associated diarrhoea and CDI, and COVID-19.

Approx Length

30 minutes

Genetic Characterisation of C.diff

C. difficile genetics, molecular characterisation and surveillance of ribotypes and strain types, and prevalent ribotypes and strain types in the UK and Ireland.

Approx Length

30 minutes

CDI Webinar Series

This module is divided into various training videos which cover everyday clinical practice and the latest topics in Clostridioides difficile infection featuring guest speakers.

Approx Length

60 minutes each

Revisit the Tillotts CDI Webinars

These webinars cover everyday clinical practice and the latest topics in Clostridioides difficile infection (approx time for all of them 1 hour)

CDI Webinar Series 2025
Part 1:

What is a healthy gut microbiome and what does it mean for C. difficile infection

  • Professor Glenn Gibson
  • Professor Mark Wilcox OBE
  • Part 2:

    How do we treat effectively? The cost-effectiveness debate

  • Dr Tim Planche
  • Dr Simon Goldenberg
  • Part 3:

    The burden of recurrence and its impact on patients

  • Professor Mark Wilcox OBE
  • Dr Jane Freeman
  • Part 4:

    Are we missing patients? Diagnosis, contamination and spread/managing an outbreak

  • Dr Kerrie Davies MBE
  • Martin Kiernan
  • Part 5:

    A high risk disease, who are most vulnerable?

  • Ahmad Simreekheea (Royal Marsden Antimicrobial Pharmacist)
  • Part 6:

    Antimicrobial stewardship and its impact on CDI treatment

  • Prof. Mark Gilchrist (Consultant IPC Pharmacist)
  • Stephen Hughes (Antimicrobial Pharmacist)
  • Part 7:

    Are all treatments equal?

  • Dr Simon Goldenberg
  • Prof. Karen Burns
  • Dr Tim Planche
  • CDI Webinar Series 2026
    Part 1:

    Raising the Standard of C.difficile Care in 2026: Patients Priorities, and the C.Diff Trust

  • Dr Kerrie Davies MBE
  • Dr Jane Freeman
  • Dr Michael Perry
  • Part 2:

    Tackling C.difficile at the coal face: From evidence to action

  • Matt Christie
  • Dr Timothy Planche
  • Oliver Troise
  • Report a side effect

    Adverse events should be reported. Reporting forms and information can be found at:

    www.mhra.gov.uk/yellowcard

    Adverse events should also be reported to Tillotts Pharma UK Ltd on:

    T. 01522 813500

    E. uksafety@tillotts.com

    PU-03395 | July 2026